1. ALLA AKTIER
  2. NYHETER
  3. PROSTALUND

ProstaLund

Nyheter ProstaLund Nyheter alla bolag

Very strong sales in the quarter, + 53 %

MAR

– Fifth consecutive quarter of growth

1 April-30 June

  • Net sales reached SEK 5,4 (3,5) million
  • Loss after taxes SEK -4,1 (-3,7) million
  • Earnings per share were SEK -0,07 (-0,07)
  • Cash and equivalents were 34,4 (4,4) million

Significant events during period

  • Distribution agreement signed in Poland
  • Distribution agreement signed in Switzerland
  • The Board decides on a rights issue
  • The rights issue was subscribed to 85% and brought the company approximately SEK 34 million in capital before issue costs

1 January-30 June

  • Net sales reached SEK 10,9 (8,1) million
  • Loss after taxes SEK -7,3 (-5,8) million
  • Earnings per share were SEK -0,10 (-0,11)

Significant events after the period

  • The company decided to withdraw the 510(k) application in the USA, for the Schelin Catheter®
  • The company decided that it intends to apply De Novo for Schelin Catheter®
Nyckeltal


(SEK MILLION) )Jan-June
2023		Jan-June
2022		Jan-June
2021
Net sales118,18,5
Gross margin, %687687
Operating profit/loss-7,2-5,8-3,9
Cash flow from operating activities-6,1-9,5-3,2
Average number of employees977

”The great interest in all our products, not only the stand-alone products but also CoreTherm, in several countries makes us look with confidence to the future”.

Johan Wennerholm
CEO, ProstaLund AB (publ)

For further information, please contact:

Johan Wennerholm,  CEO
Tel. +46 (0) 730 429997
Email: johan.wennerholm@prostalund.com

About ProstaLund

ProstaLund AB is a Swedish medical technology company and a leading developer and manufacturer of innovative urological devices and treatments. The company’s lead product, CoreTherm, is a patented Thermotherapy treatment method for Benign Prostatic Hyperplasia (BPH) which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide. ProstaLund is listed on the Nasdaq First North Growth Market.

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

This information is information that ProstaLund AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-07-14 08:15 CEST.

Attachments

ProstaLund AB (publ) Delårsrapport Jan Jun 2023 07 14 ENG

Datum 2023-07-14, kl 08:15
Källa MFN
Bifogade filer
ProstaLund AB (publ) Delårsrapport Jan Jun 2023 07 14 ENG
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!